Eye Health News and Research

Latest Eye Health News and Research

Three-year safety data from INTREPID study of Oraya Therapy™ for wet age-related macular degeneration results announced

Oraya Therapeutics Inc. announced that full results of three-year safety follow-up data from the INTREPID study of Oraya Therapy™ for wet age-related macular degeneration (AMD) further demonstrated a favorable safety profile and also showed that there was no significant difference in vision outcomes in patients treated with Oraya Therapy compared with those receiving anti-vascular endothelial growth factor (anti-VEGF) injections alone.

15 Sep 2014

Breathing-based meditation practice can be effective treatment for PTSD

One of the greatest casualties of war is its lasting effect on the minds of soldiers. This presents a daunting public health problem: More than 20 percent of veterans returning from the wars in Iraq and Afghanistan have post-traumatic stress disorder, according to a 2012 report by RAND Corp.

12 Sep 2014

New class of compounds protect brain cells from traumatic brain injury

A new class of compounds has now been shown to protect brain cells from the type of damage caused by blast-mediated traumatic brain injury (TBI).

12 Sep 2014

Vuzix, Rochester collaborate to prescribe fashion frames, lenses for M100 Smart Glasses wearers

Vuzix® Corporation, a leading supplier of Video Eyewear and Smart Glasses products in the consumer, commercial and entertainment markets, announced today a strategic collaboration with Rochester Optical to provide fashion frames and prescription lenses for M100 Smart Glasses wearers.

11 Sep 2014

FDA approves Contrave extended-release tablets for chronic weight management

Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

11 Sep 2014

New research shows statins could reduce common diabetes complications

The development of common diabetes complications that can lead to blindness and amputations could be reduced by taking statins, indicates new research published in The Lancet Diabetes & Endocrinology.

11 Sep 2014

Professor receives award for development of anti-angiogenic therapy for retinal disease

Napoleone Ferrara, MD, distinguished professor of pathology and distinguished adjunct professor of ophthalmology at the University of California, San Diego School of Medicine and senior deputy director for basic sciences at UC San Diego Moores Cancer Center, was named today as one of seven recipients of the Ant-nio Champalimaud Vision Award in Lisbon, Portugal.

11 Sep 2014

Researchers create new vestibular test to add to comprehensive concussion evaluation

Researchers at UPMC and the University of Pittsburgh have created a new, 5- to 10-minute test that could be added to a clinician's concussion evaluation toolkit for a more comprehensive assessment of the injury.

11 Sep 2014

Senate panel hears testimony from VA inspector general

During a hearing of the Senate Veterans' Affairs Committee, Inspector General Richard J. Griffin said administrators at 13 VA health facilities lied during the investigation of waiting list issues and other improprieties.

11 Sep 2014

Get SET Early: New program to reduce mean age of ASD diagnosis in multiple cities

Autism spectrum disorder (ASD) is now estimated to impact one in every 68 children born in the United States. Yet despite its rising prevalence and the known benefits of early detection and treatment, toddlers in much of the United States are routinely not identified as possibly having ASD until well after their third birthday.

11 Sep 2014

Now, women experiencing morning sickness can benefit from Diclegis drug

Up to 85 percent of pregnant women are affected by nausea and vomiting of pregnancy (NVP), more commonly known as morning sickness.

10 Sep 2014

Japanese surgeons first to implant InnFocus MicroShunt

InnFocus, Inc. reported today that the first two surgeries have been conducted in Japan in a clinical investigational study using the InnFocus MicroShunt™ glaucoma drainage implant.

10 Sep 2014

BioLight Life Sciences declares first sale of IOPtiMate system in Hong Kong

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announces the first sale of an IOPtiMate™ system in Hong Kong.

10 Sep 2014

Researchers find that shared pain can boost actual group cooperation

What doesn't kill us may make us stronger as a group, according to findings from new research published in Psychological Science, a journal of the Association for Psychological Science.

10 Sep 2014

Center Director of Omni Eye Surgery describes promising option for managing lid disease

Omni Eye Services, a leading provider of ophthalmologic services at five locations in New York and New Jersey, today announced that Dr. Katherine M Mastrota, Center Director of Omni Eye Surgery in New York City, has written a treatment update for Contact Lenses Today describing a promising "new option for managing lid disease."

9 Sep 2014

Treatment at earliest age reduces symptoms of autism spectrum disorder

Treatment at the earliest age when symptoms of autism spectrum disorder (ASD) appear - sometimes in infants as young as 6 months old - significantly reduces symptoms so that, by age 3, most who received the therapy had neither ASD nor developmental delay, a UC Davis MIND Institute research study has found.

9 Sep 2014

New antifungal drug effective against invasive mold disease in cancer patients with less adverse effects

A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology.

8 Sep 2014

People with increased yellow in macula could maintain better vision: Study

Human eyes naturally contain yellow pigment in the macula, a spot near the center of the retina responsible for high-resolution vision. Those with more yellow in their macula may have an advantage when it comes to filtering out atmospheric particles that obscure one's vision, commonly known as haze.

5 Sep 2014

TCC enters into merger with TLCC

Twinlab Consolidated Holdings, Inc. and Twinlab Consolidation Corporation announced today that they have entered into an agreement to merge in a stock-for-stock transaction with an anticipated closing date of September 15, 2014.

5 Sep 2014

States not expanding Medicaid paying 37% of cost in other states: report

A McClatchy newspaper analysis also finds that most of the money comes from five non-expansion states: Texas, Florida, North Carolina, Georgia and Virginia. Other news outlets report on the continuing debate in a number of states.

4 Sep 2014